talksle logo

Dedicated to increasing awareness about
systemic lupus erythematosus (SLE), disease activity and related organ damage

CLINICAL PRESENTATION
AND DIAGNOSIS OF SLE

Patients with SLE may present with a variety of symptoms. The diverse clinical manifestations of SLE are the result of inflammation in affected organ systems.1

Diagnosing SLE can be challenging. At times, diagnosing a patient can be time-consuming, requiring a high level of communication between the patient and the physician. Both parties must be thoroughly engaged in the process to ensure the best possible outcome in the short term and over time.2

It is important to note that there can be a significant gap between what patients experience and what they are willing to share with their physicians.

Learn more about the intricacies and subtleties of diagnosing SLE.

In one survey, 52% of patients with SLE reported they minimize their symptoms when speaking with their physicians.3,*

*Data from the 2011 National Burden of Lupus survey was funded and developed by GSK. This survey included 957 people in the lupus community — 502 people who reported being diagnosed with SLE, 204 supporters (family members or friends) of people with lupus and 251 rheumatologists.

SYSTEMIC LUPUS ERYTHEMATOSUS
(SLE): FOCUS ON
ORGAN DAMAGE

A flipchart featuring an overview of SLE and the damage it may cause
to
organ systems.

View Now (PDF)

CLINICAL IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY ON LONG-TERM ORGAN DAMAGE

R. Elaine Lambert, MD,
in a question and answer
format.

This promotional program was developed in conjunction with and sponsored by GSK, based on an interview with R. Elaine Lambert, MD.

Dr. Lambert received a fee for participation in this program.

View Now (PDF)

What Next?

The diverse clinical manifestations of SLE are the result of inflammation in affected organ systems.1

Learn more now

References:
1. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42(9):1785-1796. http://www.ncbi.nlm.nih.gov/pubmed/10513791. Accessed February 14, 2017. 2. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73(6):958-967. http://dx.doi.org/10.1136/annrheumdis-2013-205139. Accessed February 14, 2017. 3. Lupus Foundation of America. UNVEIL Survey Fact Sheet. http://www.lupus.org/page/-/files/pdf/Unveil%20Survey
%20Fact%20Sheet.pdf. Accessed February 14, 2017.